Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Idiopathic pulmonary hemosiderosis (IPH), a subtype of diffuse alveolar hemorrhage is a rare condition, first described by Virchow in 1864. Historically, it manifests in children in the first decade of life with the combination of hemoptysis, iron deficiency anemia, and alveolar infiltrates on chest radiograph. More recently, diffuse alveolar hemorrhage has been classified by the absence or presence of pulmonary capillaritis (PC), the latter carrying a potential for a poorer outcome. While systemic corticosteroids remain the first line treatment option, other immune modulators have been trailed including hydroxychloroquine, azathioprine, 6-mercaptopurine, and cyclophosphamide with varying results. Our case demonstrates for the first time, the successful use of intravenous cyclophosphamide in the management of chronic idiopathic PC. Copyright © 2012 Wiley Periodicals, Inc.

Citation

Frances Flanagan, Louisa Glackin, Dubhfeasa M Slattery. Successful treatment of idiopathic pulmonary capillaritis with intravenous cyclophosphamide. Pediatric pulmonology. 2013 Mar;48(3):303-5

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 22573417

View Full Text